Navigation Links
Ebola Virus Thwarted After Exposure
Date:5/28/2010

Successful treatment in monkeys offers hope for humans, researchers say

FRIDAY, May 28 (HealthDay News) -- Researchers report that they've disrupted the ability of the Ebola virus to replicate in monkeys, potentially suggesting a treatment for humans who get infected with the lethal disease.

The study is the first to show that the treatment helps monkeys after exposure to the Ebola virus. Previous research showed that it worked when given as a vaccine before exposure.

The study, reported by Thomas W. Geisbert of Boston University School of Medicine and colleagues, focuses on bits of genetic material that target a protein that the virus needs to reproduce.

The notoriously deadly Ebola virus, found in Africa, causes massive bleeding and kills as many as 90 percent of the people it infects. Earlier this month, researchers reported that they'd created a vaccine that protects monkeys against three strains of the virus.

The findings were published May 27 in The Lancet.

More information

For more on research on Ebola fever and other acute viral diseases, see the National Institute of Allergy and Infectious Diseases.



-- Randy Dotinga



SOURCE: The Lancet, press release, May 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Experimental Vaccine Shields Monkeys Against Ebola
2. Scripps Research scientists reveal key structure from ebola virus
3. Anti-HIV Drugs May Help Prevent Spread of Virus
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Doctors Can Use Rotavirus Vaccine Again: FDA
8. Rotavirus Vaccine Helps Kids Avoid Severe Gastro Illness
9. Study finds rotavirus vaccine greatly reduces hospitalizations for acute gastroenteritis in children
10. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
11. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: